$RGT

CLARK CHRISTOPHER D purchased $11K of RGT

CLARK CHRISTOPHER D (President) purchased 743 shares of ROYCE GLOBAL TRUST, INC. (RGT) at $14.22 on 2026-09-30.

Original reporting
SEC EDGAR · CLARK CHRISTOPHER D
Published Oct 1, 2026, 8:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 9:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RGT
Neutral
low confidence
Mentioned
$RGT
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RGTNeutralLow
01

Why it matters

The purchase is modest and unlikely to affect market dynamics, but may be noted by short‑term traders.

02

Market read

Low relevance; a routine insider purchase with minimal market impact.

03

What to watch

Potential upcoming corporate actions not disclosed may motivate the purchase.

Relevance 4/10Novelty 3/10Timing: today

Background

Form 4 filing reports insider transactions; used by traders to gauge insider sentiment.

Company-level read

Ticker impact

$RGTNeutralLow confidence
Context

President Clark Christopher D bought 743 shares at $14.22 each, total $10,565, a new Form 4 filing.

Expected impact

possible modest buying pressure

Evidence & confidence

Purchase size is trivial relative to market cap; limited impact.

Market effects

None significant; insider activity does not affect sector trends.

No regional impact expected.

Minimal; limited to Royce Global Trust shareholders.

Counterpoint

Insider purchase could be a signal of undervaluation despite small size.

Key entities

  • Royce Global Trust, Inc.

    Issuer of the Form 4 filing.

  • Clark Christopher D

    President of Royce Global Trust, reporting the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RGTMed

ASX Runners of the Week: Argent, Peregrine, NewPeak Metals & Caspin

The article says volatility returned after Trump declared an Iran ceasefire dead, following Iranian strikes on vessels in the Strait of Hormuz and subsequent US air strikes. It notes Brent crude rose above $80/bbl and junior resources stocks rallied. It highlights ASX-listed Argent BioPharma (RGT) up 206% on a US$5.5m CannEpil licensing deal with Splash, and Peregrine Gold (PGD) up 109% and NewPeak Minerals (NPM) up 107% on early gold discoveries.